High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: Reexamination of GD1a immunolocalization

Journal of Neurochemistry

Volumn 75, Issue 1, 2000, Pages 404-412

  Lunn, Michael P T ^a,b   Johnson, L'Aurelle A ^a   Fromholt, Susan E ^a   Itonori, Saki ^a   Huang, Jian ^a   Vyas, Alka A ^a   Hildreth, James E K ^a   Griffin, John W ^a   Schnaar, Ronald L ^b,c   Sheikh, Kazim A ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b GUY S HOSPITAL   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gangliosides; GD1a; GM2 GD2 synthase; GT1b; Knockout mice; Monoclonal antibodies

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; COMPLEMENT FIXATION; CONTROLLED STUDY; DISEASE ASSOCIATION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; NEUROPATHY; NONHUMAN; PATHOGENICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; CEREBELLUM; GANGLIOSIDES; HEMOCYANIN; HUMANS; HYBRIDOMAS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEURONS;

ANIMALIA; VERTEBRATA;

EID: 0034097990     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750404.x     Document Type: Article

References (32)

1. Bouche P., Moulonguet A., Younes-Chennoufi A. B., Adams D., Baumann N., Meininger V., Leger J. M., and Said G. (1995) Multifocal motor neuropathy with conduction block: a study of 24 patients. J. Neurol. Neurosurg. Psychiatry 59, 38-44.
2. Collins B. E., Kiso M., Hasegawa A., Tropak M. B., Roder J. C., Crocker P. R., and Schnaar R. L. (1997) Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J Biol. Chem. 272, 16889-16895.
3. Declerck P. J., Carmeliet P., Verstreken M., De Cock F., and Collen D. (1995) Generation of monoclonal antibodies against autologous proteins in gene-inactivated mice. J. Biol. Chem. 270, 8397-8400.
4. DeFranco A. L. (1999) B-lymphocyte activation, in Fundamental Immunology, 4th edit. (Paul W. E., ed), pp. 225-261. Lippincott-Raven, Philadelphia.
5. Hakomori S., Handa K., Iwabuchi K., Yamamura S., and Prinetti A. (1998) New insights in glycosphingolipid function: "glycosignaling domain," a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling. Glycobiology 8, xi-xix.
6. Hartung H. P., Willison H., Jung S., Pette M., Toyka K. V., and Giegerich G. (1996) Autoimmune responses in peripheral nerve. Springer Semin. Immunopathol. 18, 97-123.
7. Hatten M. E. (1985) Neuronal regulation of astroglial morphology and proliferation in vitro. J. Cell Biol. 100, 384-396.
8. Helling F., Shang A., Calves M., Zhang S., Ren S., Yu R. K., Oettgen H. F., and Livingston P. O. (1994) GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines. Cancer Res. 54, 197-203.
9. Hildreth J. E., Gotch F. M., Hildreth P. D., and McMichael A. J. (1983) A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur. J. Immunol. 13, 202-208.
10. Ho T. W., Willison H. J., Nachamkin I., Li C. Y., Veitch J., Ung H., Wang G. R., Liu R. C., Cornblath D. R., Asbury A. K., Griffin J. W., and McKhann G. M. (1999) Anti-GDla antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann. Neurol. 45, 168-173.
11. Holmgren J., Lonnroth I., Mansson J., and Svennerholm L. (1975) Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. Proc. Natl. Acad. Sci. USA 72, 2520-2524.
12. Ikami T., Ishida H., and Kiso M. (2000) Synthesis and biological activity of glycolipids, with a focus on gangliosides and sulfatide analogs. Methods Enzymol. 311, 547-568.
13. Kawashima I., Nakamura O., and Tai T. (1992) Antibody responses to ganglio-series gangliosides in different strains of inbred mice. Mol. Immunol. 29, 625-632.
14. Kawashima I., Nagata I., and Tai T. (1996) Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies. Brain Res. 732, 75-86.
15. Kotani M., Ozawa H., Kawashima I., Ando S., and Tai T. (1992) Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides. Biochim. Biophys. Acta 1117, 97-103.
16. Kotani M., Kawashima I., Ozawa H., Terashima T., and Tai T. (1993) Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies. Glycobiology 3, 137-146.
17. Kolani M., Terashima T., and Tai T. (1995) Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex. Brain Res. 700, 40-58.
18. Liu Y., Wada R., Kawai H., Sango K., Deng C., Tai T., McDonald M. P., Araujo K., Crawley J. N., Bierfreund U., Sandhoff K., Suzuki K., and Proia R. L. (1999) A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J. Clin. Invest. 103, 497-505.
19. Mata S., Lolli F., Soderstrom M., Pinto F., and Link H. (1999) Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GDla. Mult. Scler. 5, 379-388.
20. Palestini P., Pitto M., Ferraretto A., Tettamanti G., and Masserini M. (1998) Change of ganglioside accessibility at the plasma membrane surface of cultured neurons, following protein kinase C activation. Biochemistry 37, 3143-3148.
21. Rapport M. M., Graf L., Huang Y. L., Brunner W., and Yu R. K. (1980) Antibodies to total brain gangliosides: titer and specificity of antisera. Adv. Exp. Med Biol. 125, 327-334.
22. Sadatipour B. T., Greer J. M., and Pender M. P. (1998) Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis. Ann. Neurol. 44, 980-983.
23. Schnaar R. L. (1994) Isolation of glycosphingolipids. Methods Enzymol. 230, 348-370.
24. Schnaar R. L. and Needham L. K. (1994) Thin-layer chromatography of glycosphingolipids. Methods Enzymol. 230, 371-389.
25. Schwarz A. and Futerman A. H. (1996) The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies. Biochim. Biophys. Acta 1286, 247-267.
26. Schwarz A. and Futerman A. H. (1997) Determination of the localization of gangliosides using anti-ganglioside antibodies: comparison of fixation methods. J. Histochem. Cytochem. 45, 611-618.
27. Sheikh K. A., Sun J., Liu Y., Kawai H., Crawford T. O., Proia R. L., Griffin J. W., and Schnaar R. L. (1999a) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc. Natl. Acad. Sci. USA 96, 7532-7537.
28. Sheikh K. A., Deerinck T. J., Ellisman M. H., and Griffin J. W. (1999b) The distribution of ganglioside-like moieties in peripheral nerve. Brain 122, 449-460.
29. Svennerholm L. (1994) Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog. Brain Res. 101, xi-xiv.
30. Tettamanti G., Bonali F., Marchesini S., and Zambotti V. (1973) A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim. Biophys. Acta 296, 160-170.
31. Willison H. J., Veitch J., Paterson G., and Kennedy P. G. (1993) Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiatry 56, 204-206.
32. Zhao J., Furukawa K., Fukumoto S., Okada M., Furugen R., Miyazaki H., Takamiya K., Aizawa S., Shiku H., Matsuyama T., and Furukawa K. (1999) Attenuation of interleukin 2 signal in the spleen cells of complex ganglioside-lacking mice. J. Biol Chem. 274, 13744-13747.